Sutton Wealth Advisors Inc. - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 196 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.16 and the average weighting 0.1%.

Quarter-by-quarter ownership
Sutton Wealth Advisors Inc. ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$21,510
-22.4%
3220.0%0.01%
-27.3%
Q3 2022$27,727
-3.2%
322
+0.3%
0.01%0.0%
Q2 2022$28,640
-20.7%
3210.0%0.01%
-8.3%
Q1 2022$36,109
+10.3%
321
+51.4%
0.01%
+9.1%
Q4 2021$32,746
-11.0%
212
-19.7%
0.01%
-21.4%
Q3 2021$36,780
-54.3%
264
-9.9%
0.01%
-73.6%
Q3 2018$80,426
+56.5%
293
+18.1%
0.05%
+47.2%
Q2 2018$51,378
+25.4%
2480.0%0.04%
+24.1%
Q1 2018$40,960
+20.6%
2480.0%0.03%
+16.0%
Q4 2017$33,959
+0.6%
2480.0%0.02%
-3.8%
Q3 2017$33,765
+12.1%
2480.0%0.03%
+8.3%
Q2 2017$30,107
+37.4%
248
+19.8%
0.02%
+33.3%
Q1 2017$21,909
+4.2%
2070.0%0.02%
-5.3%
Q4 2016$21,033
-0.4%
2070.0%0.02%0.0%
Q3 2016$21,126
-14.4%
2070.0%0.02%
-17.4%
Q2 2016$24,689
+11.4%
2070.0%0.02%
+9.5%
Q1 2016$22,1682070.02%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Knott David M Jr 115,000$7,6822.90%
VILLERE ST DENIS J & CO LLC 483,347$32,2872.52%
Monarch Partners Asset Management LLC 62,327$4,163,4441.23%
Chicago Capital, LLC 319,054$21,312,8201.18%
RICE HALL JAMES & ASSOCIATES, LLC 285,634$19,080,3511.09%
Stephens Investment Management Group LLC 454,416$30,713,9770.56%
Smith, Graham & Co., Investment Advisors, LP 65,372$4,366,8500.53%
WOODSTOCK CORP 55,014$3,674,9350.49%
Court Place Advisors, LLC 15,533$1,037,6050.38%
ISTHMUS PARTNERS, LLC 19,830$1,324,6440.20%
View complete list of LIGAND PHARMACEUTICALS INC shareholders